Haemonetics Corporation (HAE)

Total asset turnover

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Revenue (ttm)	US$ in thousands	2,596,175	2,424,725	2,393,776	2,373,078	2,323,237	1,114,154	1,068,622	1,011,034	987,485	954,649	935,251	904,840	862,112	882,733	901,332	944,412	989,857	1,000,660	989,046	978,061
Total assets	US$ in thousands	2,195,590	2,200,430	2,011,280	1,962,260	1,934,820	1,878,070	1,865,110	1,820,530	1,859,730	1,831,380	1,801,500	1,794,190	1,819,920	1,318,070	1,418,170	1,433,170	1,267,110	1,237,750	1,190,540	1,259,610
Total asset turnover		1.18	1.10	1.19	1.21	1.20	0.59	0.57	0.56	0.53	0.52	0.52	0.50	0.47	0.67	0.64	0.66	0.78	0.81	0.83	0.78

March 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $2,596,175K ÷ $2,195,590K
= 1.18

Haemonetics Corporation's total asset turnover has shown a fluctuating trend over the past few quarters. The company's total asset turnover ratio has generally been increasing since the end of 2020. This indicates that the company has been more effective in generating sales revenue from its total assets during this period. The highest total asset turnover ratio was observed in the most recent quarter at 1.18, suggesting that the company is efficiently utilizing its assets to generate revenue.

However, there have been periods, such as in the second half of 2022, where the total asset turnover ratio was relatively low, indicating a less efficient use of assets to generate sales. Overall, the increasing trend in total asset turnover is a positive sign for Haemonetics Corporation as it implies better asset utilization and potential for improved financial performance.